X.T.L. Biopharmaceuticals Overview
X.T.L. Biopharmaceuticals Discounted Cash Flow
DCF Analysis for XTLB.
Get informed when a big investor buys or sells
+ FollowFair Value
$6.82
Current Fair Value
$6.82
↑ 220.4% Upside
Undervalued by 220.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison